tirzepatide surmount 2 vs semaglutide: A new battle in obesity treatment Weight reduction with different doses

Notably, depemokimab is administered every six months, whereas the current biologic treatment options require injections every four to eight weeks

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial

Bottom line When comparing Jardiance and metformin, there isnt a single best choice for everyone

Have sleep apnea (can worsen breathing problems)

Standard Non-T2D trial filtering for efficacy comparisons

It is unknown whether MOUNJARO causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of tirzepatide-induced rodent thyroid C-cell tumors has not been determined